Package 50228-513-18

{"route": ["ORAL"], "spl_id": "3b53cebf-946d-b82b-e063-6394a90a5da7", "openfda": {"nui": ["N0000175635", "N0000175637"], "upc": ["0350228513180", "0350228513609"], "unii": ["9NDF7JZ4M3"], "rxcui": ["2059015"], "spl_set_id": ["3b53cebf-946c-b82b-e063-6394a90a5da7"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["ScieGen pharmaceuticals,Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (50228-513-18)", "package_ndc": "50228-513-18", "marketing_start_date": "20250804"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50228-513-60)", "package_ndc": "50228-513-60", "marketing_start_date": "20250804"}], "brand_name": "Rivaroxaban", "product_id": "50228-513_3b53cebf-946d-b82b-e063-6394a90a5da7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "50228-513", "generic_name": "Rivaroxaban", "labeler_name": "ScieGen pharmaceuticals,Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivaroxaban", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "2.5 mg/1"}], "application_number": "ANDA218117", "marketing_category": "ANDA", "marketing_start_date": "20250804", "listing_expiration_date": "20261231"}